Pancreatic Cancer Research

ResearcherUC San Diego Health SystemActive in the last 2 years

Joy Liau

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3025-0268; OpenAlex author ID A5086478992. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
68
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: 2 papers · 2023: none · 2024: 2 papers · 2025: 1 paper

Papers 7

  1. Factors Associated With Aborted Whipple Procedures for Periampullary Carcinoma: A Multicenter Case-Control Study by the SAR Pancreatic Ductal Adenocarcinoma Di… Co-author DOI 10.2214/ajr.24.32160↗
  2. Imaging for Early Detection of Pancreatic Ductal Adenocarcinoma: Updates and Challenges in the Implementation of Screening and Surveillance Programs. Co-author DOI 10.2214/ajr.24.31151↗
  3. The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals. Co-author DOI 10.6004/jnccn.2023.7097↗
  4. Standardization of EUS imaging and reporting in high-risk individuals of pancreatic adenocarcinoma: consensus statement of the Pancreatic Cancer Early Detectio… Co-author DOI 10.1016/j.gie.2021.10.025↗
  5. Standardization of MRI Screening and Reporting in Individuals With Elevated Risk of Pancreatic Ductal Adenocarcinoma: Consensus Statement of the PRECEDE Consor… Co-author DOI 10.2214/ajr.22.27859↗
  6. Recommendations for a More Organized and Effective Approach to the Early Detection of Pancreatic Cancer From the PRECEDE (Pancreatic Cancer Early Detection) Co… Co-author DOI 10.1053/j.gastro.2021.08.036↗
  7. Quantitative metric for assessment of pancreatic ductal adenocarcinoma treatment response in T1-weighted gadolinium-enhanced magnetic resonance imaging. Co-author DOI 10.21037/apc-20-25↗

Closest collaborators

The 25 strongest of 68 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chenchan Huang · 5 shared papers, 2021–2025 · strength 0.70
  2. Lyndon Luk · 3 shared papers, 2022–2025 · strength 0.48
  3. Elizabeth M. Hecht · 3 shared papers, 2022–2025 · strength 0.48
  4. Avinash R. Kambadakone · 3 shared papers, 2022–2025 · strength 0.48
  5. Samuel Joseph Galgano · 2 shared papers, 2024–2025 · strength 0.35
  6. Erik V. Soloff · 2 shared papers, 2024–2025 · strength 0.35
  7. Jessica N. Everett · 3 shared papers, 2021–2024 · strength 0.35
  8. Diane M. Simeone · 3 shared papers, 2021–2024 · strength 0.35
  9. Aaron J. Grossberg · 2 shared papers, 2021–2024 · strength 0.21
  10. Talia Golan · 2 shared papers, 2021–2024 · strength 0.21
  11. James M. Lindberg · 2 shared papers, 2021–2024 · strength 0.21
  12. Bryson W. Katona · 2 shared papers, 2021–2024 · strength 0.21
  13. Rosalie C. Sears · 2 shared papers, 2021–2024 · strength 0.21
  14. Nipun B. Merchant · 2 shared papers, 2021–2024 · strength 0.21
  15. Kasmintan A. Schrader · 2 shared papers, 2021–2024 · strength 0.21
  16. Teresa A. Brentnall · 2 shared papers, 2021–2024 · strength 0.21
  17. Andrew M. Lowy · 2 shared papers, 2021–2024 · strength 0.21
  18. Sonia S. Kupfer · 2 shared papers, 2021–2024 · strength 0.21
  19. Aimee Lee Lucas · 2 shared papers, 2021–2024 · strength 0.21
  20. Salvatore Paiella · 2 shared papers, 2021–2024 · strength 0.21
  21. Michael B. Wallace · 2 shared papers, 2021–2024 · strength 0.21
  22. Daniel C. Chung · 2 shared papers, 2021–2024 · strength 0.21
  23. Yan Bi · 2 shared papers, 2021–2024 · strength 0.21
  24. George Zogopoulos · 2 shared papers, 2021–2024 · strength 0.21
  25. Jennifer B. Permuth · 2 shared papers, 2021–2024 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.